The immunopharmacology of cyclophosphamide
Author:
- Frank L. ShandFSFrank L. Shand
- 1 January 1979
- journal article
- review article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 1 (3) , 165-171
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Drug‐promoted B cell tolerance induction: a selective activity of cyclophosphamide dependent on the tolerogenicity of thymus‐independent antigensEuropean Journal of Immunology, 1978
- Influence of molecular structure on the tolerogenicity of bacterial dextransEuropean Journal of Immunology, 1977
- Timely appraisal: Ectopic (exocellular) nucleic acid as a drug target, especially in rheumatoid arthritis and certain cancers (?)Inflammation Research, 1975
- Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.Journal of Experimental Medicine, 1975
- THE EFFECT OF CYTOTOXIC DRUGS ON GRAFT-VERSUS-HOST DISEASE IN MICETransplantation, 1971
- Specific Tolerance to Sheep Erythrocytes in Mouse Bone Marrow CellsNature, 1969
- Enhancement of Dinitrochlorobenzene (DNCB) Contact Sensitization by Cyclophosphamide in the Guinea Pig**From the Department of Dermatology, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania 19104.Journal of Investigative Dermatology, 1967
- SUPPRESSION OF TISSUE IMMUNITY BY CYCLOPHOSPHAMIDETransplantation, 1964
- Cadaveric Renal TransplantationBMJ, 1963
- Drug-induced Immunological ToleranceNature, 1959